QSP Modeling of Fibrosis in Liver, Lung, and Heart

Division: DILIsym Services


DILIsym Services expert modelers Diane Longo, Grant Generaux, and Scott Q. Siler will describe the development and use of QSP models designed to support drug development for:
• NASH (non-alcoholic steatohepatitis)
• IPF (idiopathic pulmonary fibrosis)
• new QSP models of fibrosis for additional indications

Join us and learn how QSP modeling can inform and accelerate drug development of anti-fibrotic medications and more!